Researcher Bio Now investigating the physiological roles of the AICD and also of ABP and any joint interactions between the two.
What is the greatest void to date in our knowledge of Alzheimer's Disease? Firstly, is ABP actually the nasty peptide in AD, and if so why is it produced and why only in old age? The fact that there are so many enzymes which regulate both the production of ABP (ADAM10, BACE, PS-1 etc.) and its degredation (IDE etc.) suggests that ABP has a normal physiological role. What is this and will the inevitable treatments which will soon become available that prevent ABP production have other detrimental effects through its absence?
If resources were not limited, what research projects would you pursue? Subject BACE knockout mice to stroke and altitude experiments to see how they coped/survived compared to control groups. Likewise with APP knockouts and those overexpressing ADAM10.
Clinical trials on patients to see how cerebral vasodilators affect the onset and progress of AD.
What is your leading hypothesis? Old age leads to a reduction in brain oxygen, both through a reduced metabolism and through a reduced Cerebral Blood Flow.
ABP is produced in response to lowered oxygen levels and serves as a "hypoxic adaptation" peptide. The aged brain responds to the lowered oxygen climate by increasing production of ABP, which becomes uncontrolled and leads to AD.
What piece of missing evidence would help prove it? Transgenic mouse models (such as the triple transgenic model) subjected to a lowered oxygen environment, either through stroke or altitude could show accelerated progression and pathology of the disease.